Cargando…

Oncologic outcome of colon cancer with perforation and obstruction

PURPOSE: Perforation and obstruction in colorectal cancer are poor prognostic factors. We aimed to evaluate the oncological outcomes of patients with colon cancer presenting with perforation or obstruction. METHODS: A total of 260 patients underwent surgery for colon cancer between January 2015 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kwan Mo, Jeong, Min-Jae, Yoon, Kwang Hyun, Jung, Yun Tae, Kwak, Jae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107675/
https://www.ncbi.nlm.nih.gov/pubmed/35570293
http://dx.doi.org/10.1186/s12876-022-02319-5
_version_ 1784708534685925376
author Yang, Kwan Mo
Jeong, Min-Jae
Yoon, Kwang Hyun
Jung, Yun Tae
Kwak, Jae Young
author_facet Yang, Kwan Mo
Jeong, Min-Jae
Yoon, Kwang Hyun
Jung, Yun Tae
Kwak, Jae Young
author_sort Yang, Kwan Mo
collection PubMed
description PURPOSE: Perforation and obstruction in colorectal cancer are poor prognostic factors. We aimed to evaluate the oncological outcomes of patients with colon cancer presenting with perforation or obstruction. METHODS: A total of 260 patients underwent surgery for colon cancer between January 2015 and December 2017. Among them, 54 patients who underwent emergency surgery for perforated (n = 32) or obstructive (n = 22) colon cancer were included. RESULTS: The perforation (PG, n = 32) and obstruction groups (OG, n = 22) did not differ significantly in age (p = 0.486), sex (p = 0.821), tumor stage (p = 0.221), tumor location (p = 0.895), histologic grade (p = 0.173), or 3-year overall survival rate (55.6% vs. 50.0%, p = 0.784). However, the PG had a higher postoperative complication rate (44% vs. 17%, p = 0.025), longer intensive care unit stay (4.8 days vs. 0.8 days, p = 0.047), and lower 3-year recurrence-free survival (42.4% vs. 78.8%, p = 0.025) than the OG. In the multivariate analysis, perforation was significantly increased risk of recurrence (hazard ratio = 3.67, 95% confidence interval: 1.049–12.839, p = 0.042). CONCLUSION: Patients with colon cancer initially presenting with perforation had poorer recurrence-free survival, higher postoperative complication rates, and longer ICU stays than those who had obstruction.
format Online
Article
Text
id pubmed-9107675
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91076752022-05-16 Oncologic outcome of colon cancer with perforation and obstruction Yang, Kwan Mo Jeong, Min-Jae Yoon, Kwang Hyun Jung, Yun Tae Kwak, Jae Young BMC Gastroenterol Database PURPOSE: Perforation and obstruction in colorectal cancer are poor prognostic factors. We aimed to evaluate the oncological outcomes of patients with colon cancer presenting with perforation or obstruction. METHODS: A total of 260 patients underwent surgery for colon cancer between January 2015 and December 2017. Among them, 54 patients who underwent emergency surgery for perforated (n = 32) or obstructive (n = 22) colon cancer were included. RESULTS: The perforation (PG, n = 32) and obstruction groups (OG, n = 22) did not differ significantly in age (p = 0.486), sex (p = 0.821), tumor stage (p = 0.221), tumor location (p = 0.895), histologic grade (p = 0.173), or 3-year overall survival rate (55.6% vs. 50.0%, p = 0.784). However, the PG had a higher postoperative complication rate (44% vs. 17%, p = 0.025), longer intensive care unit stay (4.8 days vs. 0.8 days, p = 0.047), and lower 3-year recurrence-free survival (42.4% vs. 78.8%, p = 0.025) than the OG. In the multivariate analysis, perforation was significantly increased risk of recurrence (hazard ratio = 3.67, 95% confidence interval: 1.049–12.839, p = 0.042). CONCLUSION: Patients with colon cancer initially presenting with perforation had poorer recurrence-free survival, higher postoperative complication rates, and longer ICU stays than those who had obstruction. BioMed Central 2022-05-15 /pmc/articles/PMC9107675/ /pubmed/35570293 http://dx.doi.org/10.1186/s12876-022-02319-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Database
Yang, Kwan Mo
Jeong, Min-Jae
Yoon, Kwang Hyun
Jung, Yun Tae
Kwak, Jae Young
Oncologic outcome of colon cancer with perforation and obstruction
title Oncologic outcome of colon cancer with perforation and obstruction
title_full Oncologic outcome of colon cancer with perforation and obstruction
title_fullStr Oncologic outcome of colon cancer with perforation and obstruction
title_full_unstemmed Oncologic outcome of colon cancer with perforation and obstruction
title_short Oncologic outcome of colon cancer with perforation and obstruction
title_sort oncologic outcome of colon cancer with perforation and obstruction
topic Database
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107675/
https://www.ncbi.nlm.nih.gov/pubmed/35570293
http://dx.doi.org/10.1186/s12876-022-02319-5
work_keys_str_mv AT yangkwanmo oncologicoutcomeofcoloncancerwithperforationandobstruction
AT jeongminjae oncologicoutcomeofcoloncancerwithperforationandobstruction
AT yoonkwanghyun oncologicoutcomeofcoloncancerwithperforationandobstruction
AT jungyuntae oncologicoutcomeofcoloncancerwithperforationandobstruction
AT kwakjaeyoung oncologicoutcomeofcoloncancerwithperforationandobstruction